guselkumab
FDA Approves Guselkumab for UC
The FDA has approved guselkumab (Tremfya, Janssen) for patients with moderately to severely active ulcerative ...
SEPTEMBER 12, 2024
Anti–IL-23 Agents Effective After Prior UC Treatment Failure
VANCOUVER, B.C.—Two different monoclonal antibodies targeting the interleukin-23 p19 subunit achieved all of ...
JANUARY 26, 2024
Advanced Therapy Combinations Show Promise in Treating IBD
Therapeutic strategies employing a combination of advanced therapies are starting to reveal promising outcomes in ...
JANUARY 17, 2024
Load more